Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 94 of the 95 references it cites were found in a registry or an index.

Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management

Open access
Stein, Alexander, Voigt, Wieland, Jordan, Karin · 2010 · Therapeutic Advances in Medical Oncology

Abstract

Diarrhea is one of the main drawbacks for cancer patients. Possible etiologies could be radiotherapy, chemotherapeutic agents, decreased physical performance, graft versus host disease and infections. Chemotherapy-induced diarrhea (CID) is a common problem, especially in patients with advanced cancer. The incidence of CID has been reported to be as high as 50-80% of treated patients (≥30% CTC grade 3-5), especially with 5-fluorouracil bolus or some combination therapies of irinotecan and fluoropyrimidines (IFL, XELIRI). Regardless of the molecular targeted approach of tyrosine kinase inhibitors and antibodies, diarrhea is a common side effect in up to 60% of patients with up to 10% having severe diarrhea. Furthermore, the underlying pathophysiology is still under investigation. Despite the number of clinical trials evaluating therapeutic or prophylactic measures in CID, there are just three drugs recommended in current guidelines: loperamide, deodorized tincture of opium and octreotide. Newer strategies and more effective agents are being developed to reduce the morbidity and mortality associated with CID. Recent research focusing on the prophylactic use of antibiotics, budesonide, probiotics or activated charcoal still have to define the role of these drugs in the routine clinical setting. Whereas therapeutic management and clinical work-up of patients presenting with diarrhea after chemotherapy are rather well defined, prediction and prevention of CID is an evolving field. Current research focuses on establishing predictive factors for CID like uridine diphosphate glucuronosyltransferase-1A1 polymorphisms for irinotecan or dihydropyrimidine-dehydrogenase insufficiency for fluoropyrimidines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1758834009355164

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 95 references

Research works printed but not linked: 9

  1. Cao, S., 1998, Cancer Res, 58, 1695
  2. Dupont, H.L., 1997, Am J Gastroenterol, 92, 1962
  3. Engelking, C., 1998, Oncol Nurs Forum, 25, 859
  4. Kehrer, D.F., 2001, Clin Cancer Res, 7, 1136
  5. Rosenoff, S.H., 2006, J Support Oncol, 4, 289
  6. Siber, G.R., 1980, Cancer Res, 40, 3430
  7. Stringer, A.M., 2007, Experimental Biology and Medicine, 232, 96
  8. Trifan, O.C., 2002, Cancer Res, 62, 5778
  9. Voigt, W., 1998, Anticancer Res, 18, 3499

Cited by

See all 500

Metadata

Authors
Stein, A., Voigt, W., & Jordan, K.
Affiliations
Martin Luther University Halle-Wittenberg (DE)
Corresponding author
Stein, Alexander
Venue
Therapeutic Advances in Medical Oncology
Published
2009-12-04
Volume
2
Issue
1
Pages
51-63
ISSN
  • 1758-8340 (ISSN-L)
  • 1758-8359
OpenAlex
W2125060052
Cited by
431
References
95
Citations by year
2026: 30 · 2025: 44 · 2024: 30 · 2023: 39 · 2022: 37 · 2021: 35 · 2020: 38 · 2019: 30 · 2018: 36 · 2017: 28 · 2016: 14 · 2015: 22 · 2014: 26 · 2013: 11 · 2012: 5
FWCI
4.15
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Therapeutic Advances in Medical Oncology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Dermatology › Chemotherapy-related skin toxicity
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
chemotherapy-induced diarrhea, pathophysiology, 5-fluorouracil, irinotecan, fluoropyrimidine, loperamide, octreotide, prophylaxis, budesonide, probiotics, activated carbon, antibiotic prophylaxis, UGT1A1 polymorphism, dihydropyrimidine dehydrogenase deficiency, predictive factors, chemotherapy side effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. https://app.cochat.ai/papers/10.1177/1758834009355164
The paper
Stein, A., Voigt, W., & Jordan, K. (2010). Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Therapeutic Advances in Medical Oncology. https://doi.org/10.1177/1758834009355164

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.